Search Results - "Maturi, Raj" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema

Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema

by Boyer, David S., MD, Yoon, Young Hee, MD, PhD, Belfort, Rubens, MD, PhD, Bandello, Francesco, MD, Maturi, Raj K., MD, Augustin, Albert J., MD, Li, Xiao-Yan, MD, Cui, Harry, MS, Hashad, Yehia, MD, Whitcup, Scott M., MD
Published in Ophthalmology (Rochester, Minn.) (01.10.2014)

Get full text

Journal Article

Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial

Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial

by Maturi, Raj K, Glassman, Adam R, Josic, Kristin, Antoszyk, Andrew N, Blodi, Barbara A, Jampol, Lee M, Marcus, Dennis M, Martin, Daniel F, Melia, Michele, Salehi-Had, Hani, Stockdale, Cynthia R, Punjabi, Omar S, Sun, Jennifer K
Published in JAMA ophthalmology (01.07.2021)

Get more information

Journal Article

Four-Year Visual Outcomes After Intravitreous Aflibercept for Vision-Threatening Complications of Diabetic Retinopathy—Reply

Four-Year Visual Outcomes After Intravitreous Aflibercept for Vision-Threatening Complications of Diabetic Retinopathy—Reply

by Sun, Jennifer K, Glassman, Adam R, Maturi, Raj K
Published in JAMA : the journal of the American Medical Association (23.05.2023)

Get full text

Journal Article

Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration: 52-Week Results of Phase 3 Randomized Controlled Study

Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration: 52-Week Results of Phase 3 Randomized Controlled Study

by Kunimoto, Derek, Yoon, Young Hee, Wykoff, Charles C, Chang, Andrew, Khurana, Rahul N, Maturi, Raj K, Agostini, Hansjürgen, Souied, Eric, Chow, David R, Lotery, Andrew J, Ohji, Masahito, Bandello, Francesco, Belfort, Jr, Rubens, Li, Xiao-Yan, Jiao, Jenny, Le, Grace, Schmidt, Werner, Hashad, Yehia
Published in Ophthalmology (Rochester, Minn.) (01.10.2020)

Get full text

Journal Article

PROSPECTIVE RANDOMIZED SUBJECT-MASKED STUDY OF INTRAVITREAL BEVACIZUMAB MONOTHERAPY VERSUS DEXAMETHASONE IMPLANT MONOTHERAPY IN THE TREATMENT OF PERSISTENT DIABETIC MACULAR EDEMA

PROSPECTIVE RANDOMIZED SUBJECT-MASKED STUDY OF INTRAVITREAL BEVACIZUMAB MONOTHERAPY VERSUS DEXAMETHASONE IMPLANT MONOTHERAPY IN THE TREATMENT OF PERSISTENT DIABETIC MACULAR EDEMA

by Shah, Sanket U, Harless, Ashley, Bleau, Laura, Maturi, Raj K
Published in Retina (Philadelphia, Pa.) (01.10.2016)

Get more information

Journal Article

Yoga, Meditation and Mind-Body Health: Increased BDNF, Cortisol Awakening Response, and Altered Inflammatory Marker Expression after a 3-Month Yoga and Meditation Retreat

Yoga, Meditation and Mind-Body Health: Increased BDNF, Cortisol Awakening Response, and Altered Inflammatory Marker Expression after a 3-Month Yoga and Meditation Retreat

by Cahn, B Rael, Goodman, Matthew S, Peterson, Christine T, Maturi, Raj, Mills, Paul J
Published in Frontiers in human neuroscience (26.06.2017)

Get full text

Journal Article

Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: Three-Year Randomized Trial Results

Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: Three-Year Randomized Trial Results

by ELMAN, Michael J, HAIJING QIN, AIELLO, Lloyd Paul, BECK, Roy W, BRESSLER, Neil M, FERRIS, Frederick L, GLASSMAN, Adam R, MATURI, Raj K, MELIA, Michele
Published in Ophthalmology (Rochester, Minn.) (01.11.2012)

Get full text

Journal Article

A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY

A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY

by Maturi, Raj K, Bleau, Laura, Saunders, Jeffrey, Mubasher, Mohamed, Stewart, Michael W
Published in Retina (Philadelphia, Pa.) (01.08.2015)

Get more information

Journal Article

Rationale for the Diabetic Retinopathy Clinical Research Network Treatment Protocol for Center-Involved Diabetic Macular Edema

Rationale for the Diabetic Retinopathy Clinical Research Network Treatment Protocol for Center-Involved Diabetic Macular Edema

by Aiello, Lloyd Paul, MD, PhD, Beck, Roy W., MD, PhD, Bressler, Neil M., MD, Browning, David J., MD, PhD, Chalam, K.V., MD, Davis, Matthew, MD, Ferris, Frederick L., MD, Glassman, Adam R., MS, Maturi, Raj K., MD, Stockdale, Cynthia R., MSPH, Topping, Trexler M., MD
Published in Ophthalmology (Rochester, Minn.) (01.12.2011)

Get full text

Journal Article

Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy

Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy

by Maturi, Raj K, Glassman, Adam R, Josic, Kristin, Baker, Carl W, Gerstenblith, Adam T, Jampol, Lee M, Meleth, Annal, Martin, Daniel F, Melia, Michele, Punjabi, Omar S, Rofagha, Soraya, Salehi-Had, Hani, Stockdale, Cynthia R, Sun, Jennifer K
Published in JAMA : the journal of the American Medical Association (07.02.2023)

Get full text

Journal Article

$Therapeutic Options in Refractory Diabetic Macular Oedema$

Therapeutic Options in Refractory Diabetic Macular Oedema

by Shah, Sanket U., Maturi, Raj K.
Published in Drugs (New York, N.Y.) (01.04.2017)

Get full text

Journal Article

Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial

Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial

by Maturi, Raj K, Glassman, Adam R, Liu, Danni, Beck, Roy W, Bhavsar, Abdhish R, Bressler, Neil M, Jampol, Lee M, Melia, Michele, Punjabi, Omar S, Salehi-Had, Hani, Sun, Jennifer K
Published in JAMA ophthalmology (01.01.2018)

Get more information

Journal Article

DEFINING "STRONG" VERSUS "WEAK" RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR CENTER-INVOLVED DIABETIC MACULAR EDEMA

DEFINING "STRONG" VERSUS "WEAK" RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR CENTER-INVOLVED DIABETIC MACULAR EDEMA

by Sun, Jennifer K, Beaulieu, Wesley T, Melia, Michele, Ferris, 3rd, Frederick L, Maturi, Raj K, Nielsen, Jared S, Solomon, Sharon D, Jampol, Lee M
Published in Retina (Philadelphia, Pa.) (01.04.2023)

Get more information

Journal Article

INTRAOCULAR PRESSURE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE INTRAVITREAL IMPLANT IN THE 3-YEAR MEAD STUDY

INTRAOCULAR PRESSURE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE INTRAVITREAL IMPLANT IN THE 3-YEAR MEAD STUDY

by Maturi, Raj K, Pollack, Ayala, Uy, Harvey S, Varano, Monica, Gomes, Andre M V, Li, Xiao-Yan, Cui, Harry, Lou, Jean, Hashad, Yehia, Whitcup, Scott M
Published in Retina (Philadelphia, Pa.) (01.06.2016)

Get more information

Journal Article

Clinical proof of concept for anti-FGF2 therapy in exudative age-related macular degeneration (nAMD): phase 2 trials in treatment-naïve and anti-VEGF pretreated patients

Clinical proof of concept for anti-FGF2 therapy in exudative age-related macular degeneration (nAMD): phase 2 trials in treatment-naïve and anti-VEGF pretreated patients

by Pereira, Daniel S., Maturi, Raj K., Akita, Kazumasa, Mahesh, Vinaya, Bhisitkul, Robert B., Nishihata, Toshiaki, Sakota, Eri, Ali, Yusuf, Nakamura, Emiko, Bezwada, Padma, Nakamura, Yoshikazu
Published in Eye (London) (01.04.2024)

Get full text

Journal Article

Retrospective Large Database Study of Central Serous Chorioretinopathy Treatments and Visual Outcomes Analysis in the United States

Retrospective Large Database Study of Central Serous Chorioretinopathy Treatments and Visual Outcomes Analysis in the United States

by Burgett, Lauren, Aggarwal, Nitika, Latona, John, Driban, Matthew, Chhablani, Jay, Maturi, Raj K
Published in Journal of vitreoretinal diseases (Print) (01.09.2024)

Get more information

Journal Article

Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40

Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40

by Jhaveri, Chirag D., Liu, Danni, Maguire, Maureen G., Glassman, Adam R., Grigorian, Ruben A., Jampol, Lee M., Kingsley, Ronald M., MacCumber, Mathew W., Martin, Daniel F., Maturi, Raj K., Velez, Gisela, Sun, Jennifer K.
Published in Ophthalmology (Rochester, Minn.) (01.08.2024)

Get full text

Journal Article

Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular Degeneration

Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular Degeneration

by Khurana, Rahul N., Kunimoto, Derek, Yoon, Young Hee, Wykoff, Charles C., Chang, Andrew, Maturi, Raj K., Agostini, Hansjürgen, Souied, Eric, Chow, David R., Lotery, Andrew J., Ohji, Masahito, Bandello, Francesco, Belfort, Rubens, Li, Xiao-Yan, Jiao, Jenny, Le, Grace, Kim, Kimmie, Schmidt, Werner, Hashad, Yehia
Published in Ophthalmology (Rochester, Minn.) (01.07.2021)

Get full text

Journal Article

Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH

Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH

by Chan, Clement K, Mein, Calvin E, Glassman, Adam R, Beaulieu, Wesley T, Calhoun, Claire T, Jaffe, Glenn J, Jampol, Lee M, MacCumber, Mathew W, Maguire, Maureen G, Maturi, Raj K, Salehi-Had, Hani, Rofagha, Soraya, Sun, Jennifer K, Martin, Daniel F
Published in Ophthalmology (Rochester, Minn.) (01.11.2021)

Get full text

Journal Article

Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration

Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration

by Callanan, David, Kunimoto, Derek, Maturi, Raj K, Patel, Sunil S, Staurenghi, Giovanni, Wolf, Sebastian, Cheetham, Janet K, Hohman, Thomas C, Kim, Kimmie, López, Francisco J, Schneider, Susan
Published in Journal of ocular pharmacology and therapeutics (01.12.2018)

Get more information

Journal Article

1
2
3
4
5
6
Next
[6]